Clinical Trials in Pennsylvania

Showing 7461-7480 of 19,675 trials

UNKNOWN50 miles

ViSiGi LUX Bariatric Sizing and Calibration System

NCT06282094

This study investigates the new ViSiGi LUX.

Bariatric Surgery Candidate

Boehringer Labs LLC30 participantsStarted Jan 2024

York, Pennsylvania, United States

COMPLETEDPhase 1/253 miles

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

NCT03665285

This research study is studying a new drug, NC318, as a possible treatment for advanced or metastatic solid tumors.

Advanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more

NextCure, Inc.109 participantsStarted Oct 2018

Los Angeles, California, United States • New Haven, Connecticut, United States • Hackensack, New Jersey, United States +3 more locations

TERMINATEDPhase 395 miles

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

NCT04197986

This is a Phase 3 multicenter, double-blind, randomized, placebo-controlled study to evaluate the efficacy of infigratinib (an oral targeted FGFR1-3 inhibitor) versus placebo, as adjuvant treatment following surgery in adult subjects with invasive urothelial carcinoma and susceptible FGFR3 genetic alterations (mutations, and gene fusions or rearrangements) who have disease that is considered at high risk for recurrence with surgery alone. The study enrolls subjects with either bladder cancer post radical cystectomy or upper tract urothelial cancer post distal ureterectomy and/or nephrectomy. Study treatment is randomized 1:1 between infigratinib or placebo with treatment up to 1 year or until invasive local, distal, or metastatic disease recurrence confirmed by independent imaging reviewer.

Upper Tract Urothelial CarcinomasUrothelial Bladder Cancer

QED Therapeutics, a BridgeBio company39 participantsStarted Mar 2020

Tucson, Arizona, United States • Duarte, California, United States • Duarte, California, United States +140 more locations

ViSiGi LUX Bariatric Sizing and Calibration System

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Oral Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations

Find Trials by Condition in Pennsylvania

Study to Assess the Efficacy and Safety of Emapalumab in Primary Haemophagocytic Lymphohistiocytosis

Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement

Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921

A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis

Study to Evaluate Amifampridine Phosphate in Patients With MuSK-MG

Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.

A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis

A Study of hSTC810 With Advanced/Metastatic Solid Tumors (STCUBE-001)

Epithelioid Sarcoma Natural History Study

DFD01 Spray HPA Axis Suppression Study in Adolescent Patients With Moderate to Severe Plaque Psoriasis

Sorin Universal REgistry on Aortic Valve Replacement

A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life

On-X Heart Valve - 17mm Aortic and 23mm Mitral

Pathway to Detection & Differentiation of Delirium & Dementia in the Emergency Department

Platform Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With aOX40 (GSK3174998) in Participants With RRMM

Prospective SPINE Registry

Losmapimod Safety and Efficacy in COVID-19